Skip to content

Eton Pharmaceuticals, Inc. ETON Return on invested capital

Return on invested capital at other companies

HRO
HarrowHROW
5.7%+4.4pp
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-0.1%-0.1pp
XER
Xeris Biopharma Holdings, Inc.XERS
21.4%+15.6pp
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-475.4%+443pp
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
17.2%+15.9pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
-45.1%+1.9pp

Other financials

Income statement

See full
Revenue$24.3M+40.4%
Gross profit$14.7M+49.4%
Operating income$2.4M+614%
Net income$1.6M+199%
EPS (diluted)$0.05+183%

Balance sheet

See full
Cash & equivalents$19.7M+12.9%
Total debt$31.3M+3.7%
Total equity$30.6M+25.2%
Total assets$97.7M+16.3%

Cash flow

See full
Operating cash flow$7.4M+254%
CapEx$75.0K
Free cash flow$7.3M+251%

Valuation

See full
Market cap$930.79M+156%
Enterprise value$942.39M+150%
P/S10.7×+3.2×

Profitability

See full
Gross margin54.8%-3.7pp
Operating margin-15.1%
Net margin-9.5%-2.7pp
FCF margin17.1%

Returns & leverage

See full
Return on equity-34.2%+0.9pp
Debt / equity-0.2×
Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed November 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s return on invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s return on invested capital?
Eton Pharmaceuticals, Inc. (ETON) reported return on invested capital of -45.1% in Q3 2025.
How has Eton Pharmaceuticals, Inc.'s return on invested capital changed year-over-year?
Eton Pharmaceuticals, Inc.'s return on invested capital increased by 97.0% year-over-year, from -1,493.3% to -45.1%.
What does return on invested capital mean?
Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.